Alberta to drive Canada’s competitive edge in health innovation using AI-powered genome sequencing data for more precise, preventative and cost-effective health care. Calgary, Alberta – March 5, 2024 – Today, new investments into Alberta initiatives were announced as part of the Canadian Precision Health Initiative (CPHI) led by Genome Canada. This $81 million in […]
Rare diseases are a surprisingly common reality for Canadian families. Although each specific rare disease affects fewer than 1 in 2000 people, there are over 7000 known rare diseases. Added together, about 1 in 12 Canadians are affected by a rare disease (more than all cancers, cardiovascular disease or diagnosed diabetes), and two thirds of
The Dollars and Sense of Precision Health Testing in Alberta Read More »
Imagine receiving a custom-tailored roadmap to your health that captures the complexity of your family history, environmental factors, and entire genetic code combined. In the ever-evolving landscape of healthcare, precision health has emerged as a groundbreaking approach that is making this a reality. This new paradigm departs from a ‘one-size-fits-all’ model by using tools like
Precision Health: Using Genomics to Create a Customized Roadmap to your Health Read More »
Genome Canada announces $6M investment for enhancing early-warning systems to promote public health and $2.88M for improving the treatment of autoimmune diseases. From insights to impact we are putting genomics to work on promoting public health. Generating better information on pathogens and other influenza-like illnesses and diseases is vital for supporting decision making by
New investments drive cutting-edge R&D in health in Alberta Read More »
Newly developed technology out of the University of Calgary is 2.5x faster at diagnosing bloodstream infections than what is currently being used in health care. The time it takes to diagnosis a bloodstream infection can be the difference between life and death A difference in hours can be lifesaving when it comes to diagnosis
Understanding maternal health at the cellular level can help make dietary recommendations for a healthy pregnancy A pregnant woman’s diet affects not only her own maternal health but that of the developing fetus. But how can doctors know what diet to recommend that could increase the chances of a healthy pregnancy and baby? Scientists can
New technique uses the study of small molecules to understand maternal and fetal health Read More »
Follow Genome Alberta on social media to stay informed, expand your network and discover new resources.
© 2023 Genome Alberta. All rights reserved.
Genome Alberta respectfully acknowledges that our head office is located on Treaty 7 territory of the Blackfoot confederacy, Siksika, Kainai and Piikani First Nations, as well as the Stoney Nakoda and Tsuut’ina First Nations. We acknowledge that this territory is home to the Metis Nation of Alberta, Region 3, within the historical Northwest Metis homeland.
We will continue the work of healing and reconciliation in our communities and look forward to building a path to lead us to a better relationship with Indigenous Peoples and the environment around us based on peace, friendship and respect.
https://genomealberta.ca/new-technique-uses-the-study-of-small-molecules-to-understand-maternal-and-fetal-health/
